>peptide 1 (65 aa)
AIKQAKDWGSAHYIRKLFVLLLLTATMSKSEQVWDQTWHWMADDIVYNYKKSSTSPSQIFYFSFH*
>peptide 2 (76 aa)
MTLSIIIKNHQQVQVKYFIFHFINGFYNPIWTISASNQGFKILNESQIPNFPNFNRCISNEIGWLSSNVSFNLFII*
>peptide 3 (30 aa)
GNQTSKRLGFSTLYKKAICVVTFNCNNEQI*
>CNT0002068
AGGCAATCAAACAAGCAAAAGACTGGGGTTCAGCACATTATATAAGAAAGCTATTTGTGTTGTTACTTTTAACTGCAACAATGAGCAAATCTGAACAAGT
TTGGGACCAAACTTGGCATTGGATGGCTGATGACATTGTCTATAATTATAAAAAATCATCAACAAGTCCAAGTCAAATATTTTATTTTTCATTTCATTAA
TGGCTTTTACAACCCAATCTGGACTATCTCTGCGTCAAATCAAGGCTTCAAAATATTGAACGAGAGTCAGATCCCCAATTTTCCCAACTTTAACAGATGC
ATTTCCAATGAGATTGGCTGGTTGAGCAGTAATGTTTCCTTTAACCTCTTCATCATTTGAAAAAGATCTCTTTCCTCCCAATAAAC
Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
---|---|---|---|---|---|---|---|---|
GLYMA06G37470.1 | Uncharacterized protein | protein coding | CNT0002068 | 538 | 211 | CDS | Trans |